1. Breitz HB, Weiden PL, Vanderheyden JL. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials.J Nucl Med 33: 1099–1112, 1992.
2. Breitz HB, Fisher DR, Weiden PL, Durham JS, Ratliff BA, Bjorn MJ, et al. Dosimetry of rhenium-186-labeled monoclonal antibodies: methods, prediction from technetium-99m-labeled antibodies and results of phase I trials.J Nucl Med 34: 908–917, 1993.
3. Eary JF, Durack L, Williams D, Vanderheyden J-L. Considerations for imaging Re-188 and Re-186 isotopes.Clin Nucl Med 15: 911–916, 1990.
4. John E, Thakur ML, DeFulvio J, McDevitt MR, Damjanov I. Rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: preparation and evaluation.J Nucl Med 34: 260–267, 1993.
5. Beaumier PL, Venkatesan P, Vanderheyden J-L, Burgua WD, Kunz LL, Fritzberg AR, et al.186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice.Cancer Res 51: 676–681, 1991.